IFNL1 and rheumatoid arthritis: Elevated levels of GzmM in synovial fluid from patients with RA compared to OA controls have been shown to stimulate human fibroblasts to release IL-29, a proinflammatory cytokine, and type III interferon (IFN-λ1), suggesting that GzmM may play a local role in the pathophysiology of RA (139).